Dong Sung Bio Pharm.Co.,Ltd. (002210.KS) stock: key figures, P/E, revenue and dividend
Health Care · Pharmaceuticals · South Korea · ISIN KR7002210003
Dong Sung Bio Pharm.Co.,Ltd. financials
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Revenue | 88.45 bn KRW | 87.17 bn KRW |
| Gross profit | 38.76 bn KRW | 37.11 bn KRW |
| Operating income | -5.73 bn KRW | -10.12 bn KRW |
| EBIT | -11.23 bn KRW | -18.94 bn KRW |
| Net income | -14.57 bn KRW | -25.74 bn KRW |
| Diluted EPS – continuing operations | -637.26 KRW | -1,054.43 KRW |
Full history since 2008, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Dong Sung Bio Pharm.Co.,Ltd.
Dong Sung Bio Pharm.Co.,Ltd. manufactures and sells pharmaceuticals and cosmetics in South Korea. The company offers over the counter drugs, such as emollient, vitamin supplement, alopecia treatment, antihistamines, liver disease treatment, fire extinguisher solvent, antiviral, eye drops, menopause treatment, sleep inducer, antipyretic, analgesic, anti-inflammatory, vascular reinforcement, broad-spectrum skin disease treatment, gum disease treatment, blood circulation improver, scar treatment, dry stomach, eye nourishment, abdominal obesity treatment, anti-soil agent, respiratory solvent, and antifungal agent. It also provides prescription drugs, including endocrine system, corticosteroids, fire extinguishing system, circulatory system, psychotropic solvents, tumor therapy, analgesic anti-inflammatory, cutaneous urinary system, antiviral, antibiotics, and respiratory system. In addition, the company offers hair dye, cosmetics, health functional supplements, nasal spray, household goods, muscle taping, disinfectant, toothpaste, anti-hair loss shampoo, and sanitary napkin. The company was founded in 1957 and is headquartered in Seoul, South Korea.
More stocks
- Tech-Top Engineering CO., LTD (6750.TWO)
- Hwashin Precision Engineering Co. Ltd (126640.KQ)
- SysJust Co., Ltd. (3158.TWO)
- SERA PROGNOSTICS, INC. (SERA)
- Oncopeptides AB (ONCO.ST)
- Mikobeaute International Co., Ltd. (6574.TWO)
- Coya Therapeutics, Inc. (COYA)
- Lucent, Inc. (LUCN)
- Powerlogics Co. Ltd (047310.KQ)
- EDU Holdings Ltd (EDU.AX)
- InnoTec TSS AG (TSS.F)
- Advanced Optoelectronic Technology Inc (3437.TW)
Not investment advice. All data without warranty, price as of 30.10.2026. Details in the risk notice.